{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:14Z","timestamp":1792773374813,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"abstract":"<jats:p>\n                    Age-related macular degeneration (AMD) is a leading cause of vision impairment and blindness in older adults, profoundly affecting millions of individuals worldwide. Cathepsins are a crucial class of proteolytic enzymes that participates in multiple biological process. However, the role of cathepsins in AMD still remains unclear. This study aims to probe into the causal relationship between cathepsins and AMD using a 2-sample Mendelian randomization (MR). Instrumental variables associated with exposure (cathepsins) and the outcome (AMD) were sourced from published genome-wide association studies. To estimate the causal effects, methodologies such as inverse variance weighted, MR-Egger, and weighted median estimation (WM) were employed. Reverse MR and multivariate MR analyses were also performed. The elevated levels of cathepsin B significantly increased the risk of dry AMD, with an odds ratio (OR) of 1.068 (95% CI\u2005=\u20051.007\u20131.133) and a\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    -value of .029). Sensitivity analyses confirmed the robustness of these findings, with no evidence of heterogeneity or pleiotropy. Reverse MR analyses indicated that total AMD might elevate levels of cathepsin E (OR\u2005=\u20051.04,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.029). Multivariate MR analysis showed significant associations between specific cathepsins and AMD subtypes, including cathepsin G and cathepsin O with significantly increasing risk. The study revealed a potential causal effect of cathepsin B on AMD, especially dry AMD. These findings provide potential therapeutic targets for AMD, and further research is needed to understand the underlying mechanisms.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042357","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T21:00:14Z","timestamp":1747083614000},"page":"e42357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cathepsins and age-related macular degeneration: A Mendelian randomization study unveiling causal relationships"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiaoyan","family":"Han","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and the Eye Institute, Eye and Ear, Nose, and Throat Hospital, Fudan University, Shanghai, PR China"},{"name":"Key NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, PR China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-2393","authenticated-orcid":false,"given":"Zhixiang","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and the Eye Institute, Eye and Ear, Nose, and Throat Hospital, Fudan University, Shanghai, PR China"},{"name":"Key NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, PR China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and the Eye Institute, Eye and Ear, Nose, and Throat Hospital, Fudan University, Shanghai, PR China"},{"name":"Key NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, PR China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3556-0046","authenticated-orcid":false,"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and the Eye Institute, Eye and Ear, Nose, and Throat Hospital, Fudan University, Shanghai, PR China"},{"name":"Key NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, PR China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261023","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","article-title":"Age-related macular degeneration.","volume":"401","author":"Guymer","year":"2023","journal-title":"Lancet"},{"key":"R2-20261023","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review.","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","article-title":"Age-related macular degeneration.","volume":"105","author":"Thomas","year":"2021","journal-title":"Med Clin North Am"},{"key":"R4-20261023","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.3390\/ijms222111837","article-title":"Medication trends for age-related macular degeneration.","volume":"22","author":"Cho","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R5-20261023","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.4266","article-title":"Mechanisms of age-related macular degeneration and therapeutic opportunities.","volume":"232","author":"van Lookeren Campagne","year":"2014","journal-title":"J Pathol"},{"key":"R6-20261023","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/ceo.14294","article-title":"Treatment of dry age-related macular degeneration: a review.","volume":"51","author":"Girgis","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"key":"R7-20261023","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/cells10092483","article-title":"Potential therapeutic candidates for age-related macular degeneration (AMD).","volume":"10","author":"Nashine","year":"2021","journal-title":"Cells"},{"key":"R8-20261023","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/jmbi.1994.0083","article-title":"Alignment\/phylogeny of the papain superfamily of cysteine proteases.","volume":"246","author":"Berti","year":"1995","journal-title":"J Mol Biol"},{"key":"R9-20261023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10495-006-3486-y","article-title":"Cathepsin-regulated apoptosis.","volume":"11","author":"Chwieralski","year":"2006","journal-title":"Apoptosis"},{"key":"R10-20261023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1673-5374.286948","article-title":"Cathepsins in neuronal plasticity.","volume":"16","author":"Tran","year":"2021","journal-title":"Neural Regen Res"},{"key":"R11-20261023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/BC.2004.040","article-title":"Comprehensive search for cysteine cathepsins in the human genome.","volume":"385","author":"Rossi","year":"2004","journal-title":"Biol Chem"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","article-title":"Lysosomal cathepsins and their regulation in aging and neurodegeneration.","volume":"32","author":"Stoka","year":"2016","journal-title":"Ageing Res Rev"},{"key":"R13-20261023","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1096\/fj.06-7924com","article-title":"Cathepsin cysteine proteases in cardiovascular disease.","volume":"21","author":"Lutgens","year":"2007","journal-title":"FASEB J"},{"key":"R14-20261023","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.molimm.2009.10.003","article-title":"Cathepsin G: roles in antigen presentation and beyond.","volume":"47","author":"Burster","year":"2010","journal-title":"Mol Immunol"},{"key":"R15-20261023","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0167-4838(99)00263-0","article-title":"Lysosomal cysteine proteases: more than scavengers.","volume":"1477","author":"Turk","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R16-20261023","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4161\/cc.3.12.1289","article-title":"Multiple roles for cysteine cathepsins in cancer.","volume":"3","author":"Joyce","year":"2004","journal-title":"Cell Cycle"},{"key":"R17-20261023","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.2147\/IJN.S455633","article-title":"Cathepsin B-activatable bioactive peptide nanocarrier for high-efficiency immunotherapy of asthma.","volume":"19","author":"Song","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"R18-20261023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.02.035","article-title":"Cathepsin B: a sellsword of cancer progression.","volume":"449","author":"Mijanovi\u0107","year":"2019","journal-title":"Cancer Lett"},{"key":"R19-20261023","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.exer.2006.05.017","article-title":"The role of cathepsins in ocular physiology and pathology.","volume":"84","author":"Im","year":"2007","journal-title":"Exp Eye Res"},{"key":"R20-20261023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.exer.2013.06.014","article-title":"Cathepsin proteases promote angiogenic sprouting and laser-induced choroidal neovascularisation in mice.","volume":"115","author":"B\u00fchler","year":"2013","journal-title":"Exp Eye Res"},{"key":"R21-20261023","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.exer.2006.03.009","article-title":"Regulation of cysteine cathepsin expression by oxidative stress in the retinal pigment epithelium\/choroid of the mouse.","volume":"83","author":"Alizadeh","year":"2006","journal-title":"Exp Eye Res"},{"key":"R22-20261023","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/pharmrev.121.000527","article-title":"Cathepsin B gene knockout improves behavioral deficits and reduces pathology in models of neurologic disorders.","volume":"74","author":"Hook","year":"2022","journal-title":"Pharmacol Rev"},{"key":"R23-20261023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-6-20","article-title":"Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011.","volume":"6","author":"Xue","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R24-20261023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.92826","article-title":"Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality.","volume":"13","author":"He","year":"2024","journal-title":"Elife"},{"key":"R25-20261023","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R26-20261023","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R27-20261023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/dyac149","article-title":"Tools for assessing quality and risk of bias in Mendelian randomization studies: a systematic review.","volume":"52","author":"Spiga","year":"2023","journal-title":"Int J Epidemiol"},{"key":"R28-20261023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R29-20261023","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R30-20261023","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R31-20261023","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R32-20261023","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R33-20261023","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5603\/FHC.2011.0078","article-title":"Cathepsin E (EC 3.4.23.34) \u2013 a review.","volume":"49","author":"Chlabicz","year":"2011","journal-title":"Folia Histochem Cytobiol"},{"key":"R34-20261023","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1097\/j.pain.0000000000001596","article-title":"Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.","volume":"160","author":"Harada","year":"2019","journal-title":"Pain"},{"key":"R35-20261023","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.ajpath.2014.06.017","article-title":"Cathepsin E promotes pulmonary emphysema via mitochondrial fission.","volume":"184","author":"Zhang","year":"2014","journal-title":"Am J Pathol"},{"key":"R36-20261023","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.celrep.2019.05.065","article-title":"Cathepsin G inhibition by Serpinb1 and serpinb6 prevents programmed necrosis in neutrophils and monocytes and reduces GSDMD-Driven Inflammation.","volume":"27","author":"Burgener","year":"2019","journal-title":"Cell Rep"},{"key":"R37-20261023","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fimmu.2020.00411","article-title":"Cathepsin G-not only inflammation: the immune protease can regulate normal physiological processes.","volume":"11","author":"Zamolodchikova","year":"2020","journal-title":"Front Immunol"},{"key":"R38-20261023","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imr.13145","article-title":"Age-related macular degeneration: a disease of extracellular complement amplification.","volume":"313","author":"de Jong","year":"2023","journal-title":"Immunol Rev"},{"key":"R39-20261023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000517520","article-title":"Age-related macular degeneration: pathophysiology, management, and future perspectives.","volume":"244","author":"Flores","year":"2021","journal-title":"Ophthalmologica"},{"key":"R40-20261023","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2353\/ajpath.2010.091027","article-title":"Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization.","volume":"176","author":"Shimada","year":"2010","journal-title":"Am J Pathol"},{"key":"R41-20261023","doi-asserted-by":"crossref","first-page":"5637075","DOI":"10.1155\/2019\/5637075","article-title":"Cathepsin B pH-dependent activity is involved in lysosomal dysregulation in atrophic age-related macular degeneration.","volume":"2019","author":"Voisin","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"R42-20261023","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Cysteine cathepsins: multifunctional enzymes in cancer.","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R43-20261023","doi-asserted-by":"crossref","first-page":"e70064","DOI":"10.1111\/jcmm.70064","article-title":"Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies.","volume":"28","author":"Cai","year":"2024","journal-title":"J Cell Mol Med"},{"key":"R44-20261023","doi-asserted-by":"crossref","first-page":"e68668","DOI":"10.1371\/journal.pone.0068668","article-title":"Cathepsin B is up-regulated and mediates extracellular matrix degradation in trabecular meshwork cells following phagocytic challenge.","volume":"8","author":"Porter","year":"2013","journal-title":"PLoS One"},{"key":"R45-20261023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/jcm10010078","article-title":"Cathepsin B localizes in the caveolae and participates in the proteolytic cascade in trabecular meshwork cells. potential new drug target for the treatment of glaucoma.","volume":"10","author":"Nettesheim","year":"2020","journal-title":"J Clin Med"},{"key":"R46-20261023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-4615-1871-6_26","article-title":"Cathepsin E and cathepsin D: biosynthesis, processing and subcellular location.","volume":"362","author":"Yamamoto","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"R47-20261023","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1158\/0008-5472.CAN-07-2048","article-title":"Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface.","volume":"67","author":"Kawakubo","year":"2007","journal-title":"Cancer Res"},{"key":"R48-20261023","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1097\/JS9.0000000000001307","article-title":"Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient, and postdischarge prophylaxis: a meta-analysis of randomized controlled trials.","volume":"110","author":"Meng","year":"2024","journal-title":"Int J Surg"},{"key":"R49-20261023","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.clnu.2023.09.008","article-title":"The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: a meta-analysis of randomized controlled trials.","volume":"42","author":"Meng","year":"2023","journal-title":"Clin Nutr"},{"key":"R50-20261023","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/CIRCRESAHA.124.324649","article-title":"Neutrophil Cathepsin G and thrombosis in COVID-19.","volume":"135","author":"Violi","year":"2024","journal-title":"Circ Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:00:31Z","timestamp":1792767631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":50,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042357","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}